viewWeedMD Inc

WeedMD announces medicinal cannabis clinical expansion into Canada’s Atlantic region

Dr. Julie Hildebrand will lead the expansion of WeedMD's North Star Wellness Virtual Patient Care Program into New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland

WeedMD Inc -
WeedMD expects its medical cannabis-based Virtual Patient Care Program will provide an exit treatment for chronic opioid use in Atlantic Canada

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) reported it has expanded its North Star Wellness Virtual Patient Care Program and access to its Starseed Medicinal products into Atlantic Canada. 

The expansion will be conducted under the leadership and medical guidance of Dr. Julie Hildebrand, a New Brunswick-based physician, who is widely recognized in the region for specializing in cannabis medicine and education. Dr. Hildebrand will leverage her extensive clinical expertise in chronic pain and diabetes while working with patients and benefits providers in New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland. 

WeedMD CEO Angelo Tsebelis said in a statement: “Expanding our coverage area to Atlantic Canada alongside a leading cannabis medicine advocate such as Dr. Hildebrand, will introduce more patients to Starseed’s unique medical platform and portfolio of treatment options.”

He added: “Together with our North Star Wellness Virtual Patient Care Program, we will continue providing consultations to new and existing patients through an advanced, accessible healthcare platform. With medical cannabis therapies and product advancements on the rise, we applaud Dr. Hildebrand as a strong cannabis proponent.”

READ: WeedMD inks cannabis supply partnership with Pax Labs

Dr. Hildebrand also weighed in, stating: “Physicians have a responsibility to carefully assess and educate patients on treatment options that may be most effective to improve their health and quality of life. It’s our duty to become well-informed and counsel patients on all available medicines and treatments that can provide the highest level of care.”

She added:  “The Starseed platform is designed to enable physicians to provide that high-bar support with cannabis, particularly as an exit treatment for chronic opioid use. I’m proud to collaborate with WeedMD on this important work in my home region in Atlantic Canada.”

The North Star Wellness platform, a wholly-owned affiliate of WeedMD, connects healthcare professionals with patients and provides medical management, education and streamlined access to clinical services. The platform, which launched in 2017, now offers its Virtual Patient Care Program as the sector transitions into virtual healthcare.

The Starseed medical marketplace, meanwhile, is built around a virtual pharmacy system that takes online orders and completes the claims management process seamlessly with insurance carriers. All WeedMD and Starseed medical patients have free access to North Star’s full suite of services.

Contact Sean at sean@proactiveinvestors.com

Quick facts: WeedMD Inc

Price: 0.43 CAD

Market: TSX-V
Market Cap: $90.41 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...


Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 12/02/2019

2 min read